Ingalls & Snyder LLC Astrazeneca PLC Transaction History

Ingalls & Snyder LLC

$2.33 Billion
Q2 2024

A detailed history of Ingalls & Snyder LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Ingalls & Snyder LLC holds 63,049 shares of AZN stock, worth $4.74 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

63,049

Previous 63,990 1.47%

Holding current value

$4.74 Million

Previous $4.34 Million 13.43%

% of portfolio

0.21%

Previous 0.19%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$66.81 - $80.83 $62,868 - $76,061	-941 Reduced 1.47%	63,049 $4.92 Million
Q1 2024 May 13, 2024	SELL	$61.03 - $69.57 $8,788 - $10,018	-144 Reduced 0.22%	63,990 $4.34 Million
Q4 2023 Jan 29, 2024	SELL	$61.89 - $69.28 $96,424 - $107,938	-1,558 Reduced 2.37%	64,134 $4.32 Million
Q3 2023 Nov 02, 2023	BUY	$64.85 - $71.7 $188,583 - $208,503	2,908 Added 4.63%	65,692 $4.45 Million
Q2 2023 Jul 27, 2023	SELL	$69.91 - $75.81 $29,781 - $32,295	-426 Reduced 0.67%	62,784 $4.49 Million
Q1 2023 May 09, 2023	SELL	$63.15 - $71.6 $31,196 - $35,370	-494 Reduced 0.78%	63,210 $4.39 Million
Q4 2022 Jan 31, 2023	SELL	$54.21 - $70.44 $273,543 - $355,440	-5,046 Reduced 7.34%	63,704 $4.32 Million
Q3 2022 Oct 21, 2022	SELL	$53.02 - $135.75 $8,960 - $22,941	-169 Reduced 0.25%	68,750 $3.77 Million
Q2 2022 Aug 11, 2022	SELL	$59.26 - $71.14 $83,734 - $100,520	-1,413 Reduced 2.01%	68,919 $4.55 Million
Q1 2022 May 09, 2022	SELL	$55.72 - $67.12 $219,536 - $264,452	-3,940 Reduced 5.3%	70,332 $4.67 Million
Q4 2021 Feb 11, 2022	SELL	$54.02 - $63.83 $21,824 - $25,787	-404 Reduced 0.54%	74,272 $4.33 Million
Q3 2021 Oct 27, 2021	BUY	$55.56 - $60.79 $2.35 Million - $2.57 Million	42,302 Added 130.67%	74,676 $4.49 Million
Q2 2021 Aug 03, 2021	SELL	$48.42 - $60.18 $192,227 - $238,914	-3,970 Reduced 10.92%	32,374 $1.94 Million
Q1 2021 Apr 21, 2021	SELL	$47.16 - $54.44 $13,440 - $15,515	-285 Reduced 0.78%	36,344 $1.81 Million
Q4 2020 Jan 27, 2021	BUY	$48.52 - $58.02 $1.78 Million - $2.13 Million	36,629 New	36,629 $1.83 Million
Q3 2020 Oct 21, 2020	SELL	$53.07 - $61.1 $1.3 Million - $1.5 Million	-24,579 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$43.1 - $55.31 $92,234 - $118,363	-2,140 Reduced 8.01%	24,579 $1.3 Million
Q1 2020 Apr 22, 2020	BUY	$37.79 - $51.33 $1.01 Million - $1.37 Million	26,719 New	26,719 $1.19 Million
Q4 2019 Jan 15, 2020	SELL	$42.46 - $50.46 $1.05 Million - $1.24 Million	-24,616 Closed	0 $0
Q3 2019 Oct 16, 2019	SELL	$40.12 - $45.47 $2,005 - $2,273	-50 Reduced 0.2%	24,616 $1.1 Million
Q2 2019 Jul 11, 2019	SELL	$37.28 - $41.68 $44,139 - $49,349	-1,184 Reduced 4.58%	24,666 $1.02 Million
Q4 2018 Jan 24, 2019	SELL	$36.86 - $41.49 $30,630 - $34,478	-831 Reduced 3.11%	25,850 $982,000
Q3 2018 Oct 24, 2018	BUY	$34.76 - $39.72 $69,520 - $79,440	2,000 Added 8.1%	26,681 $1.06 Million
Q2 2018 Aug 10, 2018	SELL	$34.55 - $37.05 $8,292 - $8,892	-240 Reduced 0.96%	24,681 $867,000
Q4 2017 Jan 19, 2018	BUY	$32.09 - $34.78 $799,714 - $866,752	24,921	24,921 $865,000

Others Institutions Holding AZN

# of Institutions

1,343

Shares Held

492M

Call Options Held

4.99M

Put Options Held

3.19M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $233B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.

Account

Ingalls & Snyder LLC Astrazeneca PLC Transaction History